Keywords: merck, kgaa, lifted, erbitux, trial, review, germany

Merck KGaA lifted by Erbitux trial review

Article | 07 April 2003

Print This

Merck KGaA of Germany has reported that an independent review of itsEuropean Phase III trial of Erbitux (cetuximab), a candidate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in